ArticleJournal of pineal research2015

Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal.

Shulin Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.